Chronic Exposure of 5-Alpha Reductase Inhibitor in Young Male Rats Induces Metabolic Disturbance and Depressive-Like Behaviors
December 2023
in “
Alzheimer's & Dementia
”
New to Finasteride? There is a guide in the encyclopedia. Read the guide → 
Studysummary In this study, chronic exposure to finasteride induced metabolic disturbances and depression-like behaviors in young male rats, similar to those caused by obesity, but did not worsen anxiety or depression in obese rats. Our plain-language summary of this paper — not a Tressless recommendation.
The study "Chronic Exposure of 5‐Alpha Reductase Inhibitor in Young Male Rats Induces Not Only Metabolic Disturbance, But Also Depressive‐Like Behaviors as Similar with Obese Condition" involved 20 male Wistar rats, divided into two groups of 10. One group was fed a normal diet (ND), the other a high-fat diet (HFD) for 18 weeks. From week 13, each group was further divided to receive either a control vehicle or Finasteride (FIN), a 5-alpha reductase inhibitor used in treating androgenetic alopecia and benign prostatic hyperplasia. The study found that HFD-fed rats developed obesity and hypercholesterolemia, with increased systemic oxidative stress. These rats, along with the FIN-treated ND-fed rats, exhibited anxiety and depressive-like behaviors. However, FIN did not worsen these behaviors in HFD-fed rats. The study concluded that chronic exposure to FIN can induce metabolic disturbances and depressive-like behaviors similar to those seen in obesity.
